JOANA VON DER LINN: Open Payments
NPI 1861165136 · SYOSSET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,750 in 58 payments from 15 companies in 2025. Trend: 2023 $960 · 2024 $2,259 · 2025 $1,750
Food & beverage: $1,750
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $353 |
| Madrigal Pharmaceuticals | 5 | $352 |
| ABBVIE INC. | 14 | $324 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $210 |
| PFIZER INC. | 1 | $124 |
| Aimmune Therapeutics, Inc. | 3 | $78 |
| Ardelyx, Inc. | 2 | $58 |
| Lilly USA, LLC | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Braintree Laboratories, Inc. | 1 | $42 |
Products named: DUPIXENT, REZDIFFRA, XIFAXAN, SKYRIZI, RINVOQ, VELSIPITY, ZENPEP, IBSRELA.
Industry payments across NY — which companies pay providers there.
